-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology
Lifestyle Content
Technology
-
Governor Braun Proclaims October Careers in Construction Month
-
Carrier Factory Authorized Dealer Adams Refrigeration Sets the Standard for AC Installation in Phoenix, AZ
-
Construction Industry Council of Westchester & Hudson Valley Launches Campaign to Promote Careers in Construction Trades
-
OPERATION EDITH: FIRE SAFETY RESOURCES TO EDUCATE NORTH CAROLINA CHILDREN
-
Trained Advisor Named an OpenAI Select Partner
Entertainment
-
The Empty Pockets Announce $285,000 “Billionaire Pricing” for Their New Album
-
54Kvets Calls for Deeper TCAVA Reporting
-
New History Lifts the “Veil of Neutrality” to Reveal Ireland’s Hidden Role in the Second World War
-
Ghana Foreign Minister Addresses ICC and Durban Declaration at UN Meeting
-
Ignite Advances Liquidity Access for Cross-Chain Assets and Networks Seeking New Market Pathways
Health
-
AMERISAFE Announces 2026 Third Quarter Earnings Release and Conference Call Schedule
-
GrafTech Announces Third Quarter 2026 Earnings Conference Call and Webcast
-
Pentair Completes Acquisition of Taco Group Holdings
-
NorthStar Earth & Space Completes Business Combination with Viking
-
BrightSpire Capital, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call Dates
